CD8A and neoplasm: Tumor antagonist immune cells include effector T cells (such as cluster of differentiation 8 [CD8+] cytotoxic T cells and CD4+ effector T cells), natural killer (NK) cells, dendritic cells, M1-type macrophages and N1-type neutrophils, which contribute to suppress tumor growth.